Loading...
OTCM
BNYN
Market cap1kUSD
May 20, Last price  
0.00USD
Name

Banyan Corp

Chart & Performance

D1W1MN
OTCM:BNYN chart
P/E
P/S
0.00
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
80.60%
Revenues
5m
-8.21%
141,176511,909409,425798,1281,753,000465,7291,090,7905,450,9975,003,690
Net income
-5m
L+34.29%
-538,889-2,239,666-970,409-465,331-3,919,373-2,459,928-4,645,817-4,083,102-5,483,021
CFO
-2m
L+116.39%
-337,214-19,399-190,343-97,587-632,997-1,246,307-1,144,375-836,682-1,810,461

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Banyan Corp., operating through its subsidiaries, focuses on franchising chiropractic clinics throughout North America. The company provides extensive support to its franchisees and licensees, including specialized practice development training and assistance tailored for chiropractors. Beyond its franchising activities, Banyan delivers vital diagnostic testing services. A key offering is Nerve Conduction Velocity (NCV) testing, which is administered to patients via healthcare professionals such as doctors and chiropractors. This NCV testing is instrumental in evaluating the transmission of nerve impulses, identifying irregularities within the nervous system, and supplying objective data to substantiate treatment expenses for patients and their insurance providers. Furthermore, Banyan manufactures and markets its proprietary VT3000, an advanced nerve testing system. This system is engineered for the precise diagnosis of neuropathies – conditions affecting the peripheral nerves and spinal regions – alongside nerve irritation and other forms of nervous system damage in patients. Established in 1978, Banyan Corp. maintains its headquarters in Beverly Hills, California.
URL
IPO date
Jun 21, 2001
Employees
20
Domiciled in
US
Incorporated in
US

Valuation

No data to show